Menge C, Dean-Nystrom E A
Institute for Hygiene and Infectious Diseases of Animals, Justus-Liebig-University, D-35392 Giessen, Germany.
J Dairy Sci. 2008 Jun;91(6):2284-98. doi: 10.3168/jds.2007-0937.
Administration of dexamethasone (DEX) to cattle is commonly used in models of stress-induced effects on host defense, including models investigating interactions of microorganisms with their host. Much less is known about the effects of DEX on the adaptive immune response in cattle compared with other species. The objective of the present study was to characterize subsets of circulating lymphocytes in calves before and 48 h after the onset of parenteral DEX treatment. Treatment significantly reduced the overall percentage of circulating lymphocytes and disproportionately depleted the population of gammadeltaTCR(+)/CD8alpha(-) cells. Analysis within the CD8alpha(+) population of T cells revealed that DEX treatment also reduced the CD8alpha(low) subset of gammadeltaT cells coexpressing the activation marker ACT-2(+). By contrast, DEX treatment did not affect the percentage of CD8alpha(low)/CD25(+) cells, indicating that cells with a special activation state were affected. Dexamethasone treatment reduced the number of gammadeltaT cells but increased the percentages of CD14(+) monocytes and activated CD25(+) cells (both CD4(-) and CD4(+)) in peripheral blood mononuclear cell (PBMC) preparations. Although DEX treatment reduced the overall proliferative capacity of PBMC, it enhanced the relative number of proliferating CD4(+) lymphocytes. Lower levels of mRNA for several Th-prototype cytokines (IL-2, IFN-beta, IL-4, transforming growth factor-beta) were detected in short-term PBMC cultures established from DEX-treated calves compared with PBMC cultures from control calves; the amount of il-10 transcripts, however, was unaffected. Results of the study reported here clearly show that DEX treatment does not uniformly suppress the bovine immune system but has differential effects on lymphocyte sub-populations and functions. This information must be considered when using DEX treatment as a bovine stress model.
给牛注射地塞米松(DEX)常用于应激诱导宿主防御效应的模型,包括研究微生物与其宿主相互作用的模型。与其他物种相比,DEX对牛适应性免疫反应的影响所知甚少。本研究的目的是表征犊牛在非肠道DEX治疗开始前和开始后48小时循环淋巴细胞的亚群。治疗显著降低了循环淋巴细胞的总体百分比,并使γδTCR(+)/CD8α(-)细胞群体不成比例地减少。在CD8α(+) T细胞群体内的分析显示,DEX治疗还减少了共表达激活标记ACT-2(+)的γδT细胞的CD8α(low)亚群。相比之下,DEX治疗不影响CD8α(low)/CD25(+)细胞的百分比,表明具有特殊激活状态的细胞受到了影响。地塞米松治疗减少了γδT细胞的数量,但增加了外周血单核细胞(PBMC)制剂中CD14(+)单核细胞和活化的CD25(+)细胞(CD4(-)和CD4(+))的百分比。尽管DEX治疗降低了PBMC的总体增殖能力,但它增加了增殖的CD4(+)淋巴细胞的相对数量。与来自对照犊牛的PBMC培养物相比,在由DEX处理的犊牛建立的短期PBMC培养物中检测到几种Th原型细胞因子(IL-2、IFN-β、IL-4、转化生长因子-β)的mRNA水平较低;然而,il-10转录本的量未受影响。此处报道的研究结果清楚地表明,DEX治疗并非均匀地抑制牛免疫系统,而是对淋巴细胞亚群和功能有不同影响。在将DEX治疗用作牛应激模型时必须考虑这些信息。